FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine, more specifically to a new chemical compound, a 3-(2,2,2-trimethylhydrazinium)propionate-5-nicotinate hydroxide 3-(2,2,2-trimethylhydrazinium)potassium propionate derivative, (CH3)3N+HCH2CH2COOKRCOO- wherein exhibiting antiischemic activity.
EFFECT: what is produced and described is the new compound which may be effective as an agent showing antiischemic activity.
1 cl, 1 ex, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
3-(2,2,2-TRIMETHYLHYDRAZINIUM) PROPIONATE DERIVATIVE - POTASSIUM GLYCINATE 3-(2,2,2-TRIMETHYLHYDRAZINIUM) PROPIONATE | 2011 |
|
RU2457198C1 |
3-(2,2,2-TRIMETHYLHYDRAZINIUM) PROPIONATE-NICOTINATE 3-(2,2,2-TRIMETHYLHYDRAZINIUM) POTASSIUM PROPIONATE DERIVATIVE EXHIBITING ANTIISCHEMIC ACTIVITY | 2011 |
|
RU2458054C1 |
3-(2,2,2-TRIMETHYLHYDRAZINIUM) PROPIONATE-5-BROMNICOTINATE 3-(2,2,2-TRIMETHYLHYDRAZINIUM) POTASSIUM PROPIONATE DERIVATIVE EXHIBITING ANTIISCHEMIC ACTIVITY | 2011 |
|
RU2458690C1 |
3-(2,2,2-TRIMETHYLHYDRAZINIUM) PROPIONATE DERIVATIVE -3-(2,2,2-TRIMETHYLHYDRAZINIUM) POTASSIUM PROPIONATE NICOTINATE DERIVATIVE EXHIBITING ENDOTHELIOPROTECTIVE ACTIVITY | 2011 |
|
RU2465268C1 |
3-(2,2,2-TRIMETHYLHYDRAZINIUM) PROPIONATE DERIVATIVE - 3-(2,2,2-TRIMETHYLHYDRAZINIUM) POTASSIUM PROPIONATE GLYCINATE EXHIBITING ENDOTHELIOPROTECTIVE ACTIVITY | 2011 |
|
RU2467748C1 |
3-(2,2,2-TRIMETHYLHYDRAZINIUM) PROPIONATE DERIVATIVE - 3-(2,2,2-TRIMETHYLHYDRAZINIUM) POTASSIUM PROPIONATE 5-NICOTINATE HYDROXIDE EXHIBITING ENDOTHELIOPROTECTIVE ACTIVITY | 2011 |
|
RU2467744C1 |
3-(2,2,2-TRIMETHYLHYDRAZINIUM) PROPIONATE DERIVATIVE - 3-(2,2,2-TRIMETHYLHYDRAZINIUM) POTASSIUM PROPIONATE 5-BROMNICOTINATE EXHIBITING ENDOTHELIOPROTECTIVE ACTIVITY | 2011 |
|
RU2467745C1 |
METHOD FOR INHIBITING NUCLEAR FACTOR KAPPA B WITH USE OF 5-HYDROXYNICOTINATE 3-(2,2,2-TRIMETHYLHYDRAZINIUM) POTASSIUM PROPIONATE IN CELL CULTURE | 2017 |
|
RU2674443C1 |
METHOD FOR SYNTHESIS OF DIHYDRATE OF 3-(2,2,2-TRIMETHYLHYDRAZINIUM)-PROPIONATE | 2008 |
|
RU2404159C2 |
ANTI-ISCHEMIC DRUG | 2012 |
|
RU2499593C1 |
Authors
Dates
2012-07-27—Published
2011-05-31—Filed